LifeStance Health Group, Inc. Net Fee Amt
LifeStance Health Group, Inc. (LFST) had Net Fee Amt of $38.99 thousand as of 2026-09-09, per its 424B7 filed 2026-09-10.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-09-10
- 2026-09-09: Net Fee Amt $38.99K.
- 2026-05-08: Net Fee Amt $39.39K.
| Period end | Net Fee Amt |
|---|---|
| 2026-09-09 | $38.99K 424B7 · filed 2026-09-10 |
| 2026-05-08 | $39.39K 424B7 · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |